Results 131 to 140 of about 20,588,866 (381)

Evaluating innovation policy: a structural treatment effect model of R&D subsidies [PDF]

This paper studies the welfare effects of R&D subsidies. We develop a model of continuous optimal treatment with outcome heterogeneity where the treatment outcome depends on applicant investment.
Takalo, Tuomas, Tanayama, Tanja, Toivanen, Otto   +2 more
core  

A retrospective study on 195 horses with contaminated and infected synovial cavities [PDF]

, 2009
This study analyzes the clinical aspects of contaminated and infected synovial cavities in horses and evaluates their prognosis after treatment. The medical records of 195 affected horses referred between June 1999 and July 2004 were reviewed. Twenty-six
Dewulf, Jeroen, Dumoulin, Michèle, Gasthuys, Frank, Martens, Ann, Oosterlinck, Maarten, Pille, Frederik   +5 more
core   +1 more source

MSI as a predictive factor for treatment outcome of gastroesophageal adenocarcinoma.

Cancer Treatment Reviews, 2020
M. Velzen, S. Derks, N. Grieken, N. H. Mohammad, H. Laarhoven   +4 more
semanticscholar   +1 more source

A randomized trial of intraarterial treatment for acute ischemic stroke.

New England Journal of Medicine, 2015
BACKGROUND In patients with acute ischemic stroke caused by a proximal intracranial arterial occlusion, intraarterial treatment is highly effective for emergency revascularization. However, proof of a beneficial effect on functional outcome is lacking.
O. Berkhemer, P. Fransen, D. Beumer, Lucie A van den Berg, Hester F. Lingsma, A. Yoo, W. Schonewille, J. Vos, P. Nederkoorn, M. Wermer, M. V. van Walderveen, J. Staals, J. Hofmeijer, J. V. van Oostayen, G. J. Lycklama à Nijeholt, J. Boiten, P. Brouwer, B. Emmer, S. D. de Bruijn, Lukas C. van Dijk, L. Kappelle, Rob H. Lo, E. V. van Dijk, J. de Vries, P. D. de Kort, W. V. van Rooij, J. V. D. van den Berg, B. V. van Hasselt, L. Aerden, R. Dallinga, M. Visser, J. Bot, P. Vroomen, O. Eshghi, T. Schreuder, R. Heijboer, K. Keizer, A. Tielbeek, H. D. den Hertog, D. Gerrits, R. M. Van den Berg-Vos, G. Karas, E. Steyerberg, H. Z. Flach, H. Marquering, M. Sprengers, S. Jenniskens, L. Beenen, R. van den Berg, P. Koudstaal, W. V. van Zwam, Y. Roos, A. van der Lugt, R. V. van Oostenbrugge, C. Majoie, D. Dippel   +55 more
semanticscholar   +1 more source

Late renal toxicity of treatment for childhood malignancy: risk factors, long-term outcomes, and surveillance [PDF]

, 2017
Roderick Skinner
openalex   +1 more source

Nicotinamide N‐methyltransferase promotes drug resistance in lung cancer, as revealed by nascent proteomic profiling

Molecular Oncology, EarlyView.
AZD9291 has shown promise in targeted cancer therapy but is limited by resistance. In this study, we employed metabolic labeling and LC–MS/MS to profile time‐resolved nascent protein perturbations, allowing dynamic tracking of drug‐responsive proteins. We demonstrated that increased NNMT expression is associated with drug resistance, highlighting NNMT ...
Zhanwu Hou, Zhen Wang, Fei Yang, Xiao Han, Lei Li, Huadong Liu   +5 more
wiley   +1 more source

PARP inhibitors elicit distinct transcriptional programs in homologous recombination competent castration‐resistant prostate cancer

Molecular Oncology, EarlyView.
PARP inhibitors are used to treat a small subset of prostate cancer patients. These studies reveal that PARP1 activity and expression are different between European American and African American prostate cancer tissue samples. Additionally, different PARP inhibitors cause unique and overlapping transcriptional changes, notably, p53 pathway upregulation.
Moriah L. Cunningham, Jasibel Vasquez‐Gonzalez, Samantha M. Barnada, Salome Tchotorlishvili, Latese Jones, Ryan Maguire, Genevieve Lewis, Kinza Rizwan, Jenny Deng, Salma Koachar, Drithi Patel, Hailey Shankle, Tessa Mulders, Namra Ajmal, Charalambos Solomides, Emad S. Alnemri, Teresa F. Alnemri, Ayesha A. Shafi, Leonard G. Gomella, Wm Kevin Kelly, Steven B. McMahon, Matthew J. Schiewer   +21 more
wiley   +1 more source

Treatment Outcomes

This chapter aims to provide guidelines on implementing treatment outcome measures (TOMs) in telemedicine. It outlines the definition and the ICF classification of TOMs and highlights the considerations for integrating TOMs in telemedicine. We identified the STEERING model, which guides toward the development of effective TM systems that have the ...
Suad J. Ghaben, Arimi Fitri Mat Ludin
openaire   +1 more source

The Augmented Synthetic Control Method

, 2020
The synthetic control method (SCM) is a popular approach for estimating the impact of a treatment on a single unit in panel data settings. The "synthetic control" is a weighted average of control units that balances the treated unit's pre-treatment ...
Ben-Michael, Eli, Feller, Avi, Rothstein, Jesse   +2 more
core  

Depression, anxiety, and antidepressant treatment in women: association with in vitro fertilization outcome [PDF]

, 2016
Carolyn E. Cesta, Alexander Viktorin, Henrik Olsson, Viktoria Johansson, Arvid Sjölander, Christina Bergh, Alkistis Skalkidou, Karl‐Gösta Nygren, Sven Cnattingius, Anastasia Iliadou   +9 more
openalex   +1 more source